loader
Expertise

0+ CRS & HIPEC Procedures

Among the very few surgical oncologists in India performing CRS and HIPEC for peritoneal surface malignancies.

Performed

0+ Cancer Surgeries

Extensive experience across ovarian, peritoneal surface malignancy, endometrial, and advanced robotic cancer surgeries.

Accomplished

0+ Years of Experience

Experienced in surgical oncology, managing early and advanced stage cancers at leading tertiary care centres.

Surgical Specialities

Cancer Specialities Treated Surgically

Ovarian Cancer Surgery

Ovarian Cancer

Learn More
Peritoneal Surface Malignancy

Peritoneal Surface Malignancy

Learn More
Endometrial Cancer

Endometrial Cancer

Learn More
Breast Cancer

Breast Cancer

Learn More
Cervical Cancer

Cervical Cancer

Learn More
Head and Neck Cancer

Head and Neck Cancer

Learn More
Stomach Cancer

Stomach Cancer

Learn More
Colorectal Cancer

Colorectal Cancer

Learn More

Each patient is evaluated thoroughly to determine the most appropriate
surgical approach, ensuring personalised and evidence-based care.

Advanced Cancer Surgeries

Advanced and Robotic Cancer Procedures

Patients appreciate the clarity, confidence, and compassion provided throughout their surgical journey.

Cytoreductive Surgery (CRS) with HIPEC

Advanced surgical treatment for ovarian and peritoneal cancers involving complete or near complete tumour removal followed by heated intraperitoneal chemotherapy.

Robotic Gynaecologic Oncology Surgery

Robotic assisted surgery for uterine and selected gynaecologic cancers, allowing high precision surgical dissection while minimising surgical trauma.

Complex Ovarian Cancer Cytoreduction

Surgical management of advanced ovarian cancer cases requiring extensive tumour clearance, performed with meticulous planning and adherence to evidence based protocols.

These procedures are offered to carefully selected patients and aim for maximum tumour clearance with optimal recovery.

Facilities & Surgical Support
Shape Image

Facilities & Surgical Support

Comprehensive Surgical Care Facilities

  • Robotic surgical technology
  • Cytoreductive Surgeries
  • HIPEC/PIPAC
  • Multidisciplinary surgical support
  • Chemo Port placement
  • Stoma care and surgical stoma management

Modern infrastructure combined with focused surgical expertise ensures safe and effective care.

About Dr. Snita Sinukumar
Shape Image
Meet Our Expert

Meet Dr. Snita Sinukumar

HIPEC, Ovarian Cancer & Robotic Uterine Cancer Surgeon

Dr. Snita Sinukumar is a Surgical Oncologist with a focused practice in advanced ovarian cancer surgery, CRS and HIPEC for peritoneal malignancies, and robotic uterine (endometrial) cancer surgery.

She is among a select group of surgeons in India with advanced training and experience in cytoreductive surgery and HIPEC, supported by international fellowship training. Her work centres on achieving optimal tumour clearance in complex ovarian cancer cases.

She also performs robotic gynaecologic oncology surgery, offering precise, minimally invasive treatment with faster recovery where appropriate.

More About Dr. Snita
Testimonials

What Our Patients Say

Patients appreciate the clarity, confidence, and compassion provided throughout their surgical journey.

About Dr. Snita Sinukumar
Shape Image
Patients Trust Remedium

Why Choose Remedium Superspeciality Clinic

Icon

Focused Expertise in HIPEC & Ovarian Cancer Surgery

Icon

Surgical Oncology-Only Practice

Icon

Part of a select group of HIPEC-performing surgeons in India

Icon

Strong academic and research background

Icon

Women-centric and patient-first approach

Icon

Clear Communication & Compassionate Care

Learn More

GALLERY

Inside Our Practice

Blogs

Insights on Cancer Surgery

FAQs

Frequently Asked Questions

Robotic cancer surgery is a form of minimally invasive surgery in which specially trained surgeons use a robotic system to perform complex oncologic operations with enhanced precision, control, and 3D magnified vision.
Unlike open surgery, which involves larger incisions, robotic surgery uses small incisions and robotic instruments controlled by the surgeon to reduce tissue trauma, improve precision, and often speed up recovery.
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is performed after removing visible cancer in the abdomen and involves circulating heated chemotherapy directly in the abdominal cavity to kill microscopic cancer cells. It's typically offered to select patients with cancers that have spread within the abdomen.
Yes, robotic HIPEC surgery is a major cancer operation requiring careful preparation, general anaesthesia, and an experienced surgical team. Although minimally invasive robotic techniques are used where appropriate, it still involves extensive internal surgery.
Recovery varies by patient and cancer type, but because robotic surgery is minimally invasive, many patients experience less pain, shorter hospital stays, and earlier return to daily activities compared with traditional open surgeries.
Eligibility depends on cancer type, stage, tumour location, and overall patient health. Not all cancers are suited to robotic approaches, so careful evaluation by a surgical oncologist is essential.
As with any major surgery, risks can include bleeding, infection, bowel issues, or delayed healing. The risk profile varies by case and surgical complexity and should be discussed with your surgeon.
Before HIPEC, visible cancer deposits inside the abdominal cavity are surgically removed. This step, called cytoreductive surgery, aims to leave no visible disease or only very minimal residual disease before heated chemotherapy is delivered.
After cytoreductive surgery is completed, HIPEC typically lasts about 60 minutes, during which heated chemotherapy fluid is continuously circulated within the abdomen at controlled temperatures.
PIPAC (Pressurised Intraperitoneal Aerosol Chemotherapy) is a minimally invasive technique where chemotherapy is delivered as an aerosol into the abdominal cavity using laparoscopy. Unlike HIPEC, it does not require extensive tumour removal and may be used in selected patients where CRS is not feasible.
PIPAC may be considered for patients with peritoneal surface malignancies who are not suitable candidates for complete cytoreductive surgery, or as part of disease control in specific clinical situations. Suitability is determined after a detailed evaluation.